Recent evidence implicates that EGFR, c-erbB2 and its encoding gene HER2/neu, can also regulate CXCR4 expression at the post-transcriptional level in breast cancer cells (Benovic and Marchese, 2004; Arya et al., 2007). The gene discussed is CXCR4; the disease is breast cancer.